[IgA Nephropathy Update 2025/2026].

Immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis and has undergone a therapeutic revolution in just a few years that is unprecedented in nephrology. For the first time, the guidelines define remission as a realistic treatment goal and solidify the so-called "dual-pillar" approach. This educational article summarizes the current recommendations and developments and evaluates the clinical evidence.